Laser study for HS scars pulled before it began
NCT ID NCT05470322
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study planned to test a fractional ablative erbium laser on scarring caused by hidradenitis suppurativa (HS) in the armpit area. It was designed for adults with mild HS activity and visible scars. However, the trial was withdrawn before enrolling any participants, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Er:YAG laser (fractional ablative laser)
- What this could lead to
- If it had worked, this laser treatment could have offered a way to improve the appearance of scars from hidradenitis suppurativa.
- What could go wrong
- The trial was withdrawn before any patients were treated, so we have no data on whether the laser is effective or safe for this use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Montefiore Einstein Advanced Care
Elmsford, New York, 10523, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could childhood trauma fuel skin inflammation?
- Head-to-Head: which pill tames hidradenitis suppurativa best?
- Skin disease evolution under the microscope: a 17-Year look at what drives severity
- Could early treatment tame a painful skin condition?
- New pill shows promise for controlling painful skin condition in long-term trial
- New shot could ease painful skin condition